Literature DB >> 16751390

The complementarity determining region 2 of BV8S2 (V beta 8.2) contributes to antigen recognition by rat invariant NKT cell TCR.

Elwira Pyz1, Olga Naidenko, Sachiko Miyake, Takashi Yamamura, Ingolf Berberich, Susanna Cardell, Mitchell Kronenberg, Thomas Herrmann.   

Abstract

Invariant NKT cells (iNKT cells) are characterized by a semi-invariant TCR comprising an invariant alpha-chain paired with beta-chains with limited BV gene usage which are specific for complexes of CD1d and glycolipid Ags like alpha-galactosylceramide (alpha-GalCer). iNKT cells can be visualized with alpha-GalCer-loaded CD1d tetramers, and the binding of mouse CD1d tetramers to mouse as well as to human iNKT cells suggests a high degree of conservation in recognition of glycolipid Ags between species. Surprisingly, mouse CD1d tetramers failed to stain a discrete cell population among F344/Crl rat liver lymphocytes, although comprised iNKT cells are indicated by IL-4 and IFN-gamma secretion after alpha-GalCer stimulation. The arising hypothesis that rat iNKT TCR recognizes alpha-GalCer only if presented by syngeneic CD1d was then tested with the help of newly generated rat and mouse iNKT TCR-transduced cell lines. Cells expressing mouse iNKT TCR reacted to alpha-GalCer presented by rat or mouse CD1d and efficiently bound alpha-GalCer-loaded mouse CD1d tetramers. In contrast, cells expressing rat iNKT TCR responded only to alpha-GalCer presented by syngeneic CD1d and bound mouse CD1d tetramers only poorly or not at all. Finally, CD1d-dependent alpha-GalCer reactivity and binding of mouse CD1d tetramers was tested for cells expressing iNKT TCR comprising either rat or mouse AV14 (Valpha14) alpha-chains and wild-type or mutated BV8S2 (Vbeta8.2) beta-chains. The results confirmed the need of syngeneic CD1d as restriction element for rat iNKT TCR and identified the CDR2 of BV8S2 as an essential site for ligand recognition by iNKT TCR.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16751390     DOI: 10.4049/jimmunol.176.12.7447

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  15 in total

1.  Vβ2 natural killer T cell antigen receptor-mediated recognition of CD1d-glycolipid antigen.

Authors:  Onisha Patel; Daniel G Pellicci; Adam P Uldrich; Lucy C Sullivan; Mugdha Bhati; Melissa McKnight; Stewart K Richardson; Amy R Howell; Thierry Mallevaey; Jingjing Zhang; Romain Bedel; Gurdyal S Besra; Andrew G Brooks; Lars Kjer-Nielsen; James McCluskey; Steven A Porcelli; Laurent Gapin; Jamie Rossjohn; Dale I Godfrey
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-07       Impact factor: 11.205

2.  Alpaca (Vicugna pacos), the first nonprimate species with a phosphoantigen-reactive Vγ9Vδ2 T cell subset.

Authors:  Alina S Fichtner; Mohindar M Karunakaran; Siyi Gu; Christopher T Boughter; Marta T Borowska; Lisa Starick; Anna Nöhren; Thomas W Göbel; Erin J Adams; Thomas Herrmann
Journal:  Proc Natl Acad Sci U S A       Date:  2020-03-05       Impact factor: 11.205

3.  Direct identification of rat iNKT cells reveals remarkable similarities to human iNKT cells and a profound deficiency in LEW rats.

Authors:  Elisa Monzon-Casanova; Daniel Paletta; Lisa Starick; Ingrid Müller; Derek B Sant'Angelo; Elwira Pyz; Thomas Herrmann
Journal:  Eur J Immunol       Date:  2012-12-26       Impact factor: 5.532

4.  Key implication of CD277/butyrophilin-3 (BTN3A) in cellular stress sensing by a major human γδ T-cell subset.

Authors:  Christelle Harly; Yves Guillaume; Steven Nedellec; Cassie-Marie Peigné; Hannu Mönkkönen; Jukka Mönkkönen; Jianqiang Li; Jürgen Kuball; Erin J Adams; Sonia Netzer; Julie Déchanet-Merville; Alexandra Léger; Thomas Herrmann; Richard Breathnach; Daniel Olive; Marc Bonneville; Emmanuel Scotet
Journal:  Blood       Date:  2012-07-05       Impact factor: 22.113

5.  Vγ9 and Vδ2 T cell antigen receptor genes and butyrophilin 3 (BTN3) emerged with placental mammals and are concomitantly preserved in selected species like alpaca (Vicugna pacos).

Authors:  Mohindar M Karunakaran; Thomas W Göbel; Lisa Starick; Lutz Walter; Thomas Herrmann
Journal:  Immunogenetics       Date:  2014-02-14       Impact factor: 2.846

6.  B7-H1-deficiency enhances the potential of tolerogenic dendritic cells by activating CD1d-restricted type II NKT cells.

Authors:  Carolin Brandl; Sonja Ortler; Thomas Herrmann; Susanna Cardell; Manfred B Lutz; Heinz Wiendl
Journal:  PLoS One       Date:  2010-05-24       Impact factor: 3.240

7.  CD1d expression in paneth cells and rat exocrine pancreas revealed by novel monoclonal antibodies which differentially affect NKT cell activation.

Authors:  Elisa Monzon-Casanova; Birte Steiniger; Stefanie Schweigle; Holger Clemen; Daniela Zdzieblo; Lisa Starick; Ingrid Müller; Chyung-Ru Wang; Sara Rhost; Susanna Cardell; Elwira Pyz; Thomas Herrmann
Journal:  PLoS One       Date:  2010-09-30       Impact factor: 3.240

8.  A single amino acid defines cross-species reactivity of tree shrew (Tupaia belangeri) CD1d to human invariant natural killer T (iNKT) cells.

Authors:  Ping Zhang; Demin Li; Guillaume Stewart-Jones; Xiaoli Shao; Yuanxu Zhang; Qiongyu Chen; Yijiang Li; You-Wen He; Xiao-Ning Xu; Hua-Tang Zhang
Journal:  Immunology       Date:  2009-06-05       Impact factor: 7.397

9.  Superantigen-presentation by rat major histocompatibility complex class II molecules RT1.Bl and RT1.Dl.

Authors:  Henry Dlaske; Hatice Karaüzüm; Elisa Monzon-Casanova; Ronald Rudolf; Lisa Starick; Ingrid Müller; Gerhild Wildner; Maria Diedrichs-Möhring; Norbert Koch; Tohru Miyoshi-Akiyama; Takehiko Uchiyama; Kurt Wonigeit; Bernhard Fleischer; Silke Overbeck; Lothar Rink; Thomas Herrmann
Journal:  Immunology       Date:  2008-12-24       Impact factor: 7.397

10.  Function and expression of CD1d and invariant natural killer T-cell receptor in the cotton rat (Sigmodon hispidus).

Authors:  Alina Suzann Fichtner; Daniel Paletta; Lisa Starick; Richard F Schumann; Stefan Niewiesk; Thomas Herrmann
Journal:  Immunology       Date:  2015-10-14       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.